We unpack the FDA 510(k) summary for SubtleHD-CT, an AI software designed to enhance CT scans in the background. We explore the phantom testing parameters, the retrospective reader study results, and a crucial limitation regarding which image reconstruction types the software supports.

Key points

  • SubtleHD-CT is an AI software cleared to process and enhance CT images regardless of the scanner manufacturer or model.
  • The software runs entirely in the background without a user interface, automatically receiving images, enhancing them, and sending them to the hospital's PACS.
  • Clearance was based on substantial equivalence to a predicate device, ClariCT.AI, and included extensive phantom testing across multiple scanner brands.
  • A retrospective reader study of 270 clinical cases showed the enhanced images met the required thresholds for diagnostic utility and lack of artifacts.
  • A major limitation noted in the document is that the software is engineered for standard Filtered Back Projection; use with Iterative Reconstruction or Deep Learning reconstructions may result in unknown performance.

Source: FDA 510(k) summary K254120: SubtleHD-CT (1.x) (Subtle Medical) - U.S. Food and Drug Administration, 2026

This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-subtle-medical-subtlehd-ct-upgrading-ct-image-qualit-cc13b9

Podden och tillhörande omslagsbild på den här sidan tillhör Mike Rawson. Innehållet i podden är skapat av Mike Rawson och inte av, eller tillsammans med, Poddtoppen.